ClinicalMetric tracks all active clinical trials for ptsd sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — ptsd Clinical Trials
How many clinical trials are currently recruiting for ptsd?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for ptsd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ptsd?
ptsd research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ptsd clinical trial?
Eligibility criteria for ptsd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07283757
Recruiting
PTSD Treatment for Incarcerated Men and Women: AV
Enrollment
900 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
NCT03803332
Recruiting
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
Enrollment
208 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT06755710
Recruiting
Patient Engagement in PTSD Treatment (PEP)
Enrollment
427 pts
Location
Denmark
Sponsor
Mental Health Centre Copenhage...
NCT07523685
Recruiting
Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD)
Enrollment
40 pts
Location
United States
Sponsor
Acacia Clinics
NCT06210711
Recruiting
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
Enrollment
300 pts
Location
United States
Sponsor
Baylor Research Institute
NCT05700279
Recruiting
Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset
Enrollment
345 pts
Location
United States
Sponsor
Rush University Medical Center
NCT05516862
Recruiting
Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma
Enrollment
75 pts
Location
United States
Sponsor
Paul Crawford
NCT06127342
Recruiting
Exercise and Emotional Learning in Posttraumatic Stress Disorder
Enrollment
100 pts
Location
United States
Sponsor
Christal L Badour
NCT07346638
Recruiting
The BEAR Program for Women With Trauma Who Have Suicidal Thoughts
Enrollment
30 pts
Location
United States
Sponsor
Stanford University
NCT06876740
Recruiting
Project Safe Guard-Trauma
Enrollment
168 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06776523
Recruiting
Boosting Refugee Integration Through Psychological Intervention
Enrollment
1,200 pts
Location
Switzerland
Sponsor
University of Zurich
NCT04452500 Phase 2
Recruiting
Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)
Enrollment
40 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT07176273
Recruiting
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Enrollment
302 pts
Location
United States
Sponsor
The University of Texas Health...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology